# Lands' End, Inc.: financial statements, quarterly

LE · Nasdaq · CIK 799288 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/le.md) · [Financials](/companies/le/financials.md) · [Filings](/companies/le/filings.md) · [Insiders](/companies/le/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/le/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-27) | Q4 FY2023 (2024-02-02) | Q1 FY2024 (2024-05-03) | Q2 FY2024 (2024-08-02) | Q3 FY2024 (2024-11-01) | Q4 FY2024 (2025-01-31) | Q1 FY2025 (2025-05-02) | Q2 FY2025 (2025-08-01) | Q3 FY2025 (2025-10-31) | Q4 FY2025 (2026-01-30) | Q1 FY2026 (2026-05-01) | Q2 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [325](/filings/0000950170-24-133682.md) | [515 d](/filings/0001193125-26-126210.md) | [285](/filings/0000950170-25-082338.md) | [317](/filings/0000950170-25-113837.md) | [319](/filings/0001193125-25-312757.md) | [442 d](/filings/0001193125-26-126210.md) | [261](/filings/0001193125-26-263736.md) | [294](/filings/0001193125-26-381873.md) | [317](/filings/0001193125-25-312757.md) | [462 d](/filings/0001193125-26-126210.md) | [239](/filings/0001193125-26-263736.md) | [302](/filings/0001193125-26-381873.md) |
| Cost of revenue | $m | [172](/filings/0000950170-24-133682.md) | [319 d](/filings/0001193125-26-126210.md) | [146](/filings/0000950170-25-082338.md) | [165](/filings/0000950170-25-113837.md) | [157](/filings/0001193125-25-312757.md) | [240 d](/filings/0001193125-26-126210.md) | [128](/filings/0001193125-26-263736.md) | [151](/filings/0001193125-26-381873.md) | [153](/filings/0001193125-25-312757.md) | [253 d](/filings/0001193125-26-126210.md) | [127](/filings/0001193125-26-263736.md) | [145](/filings/0001193125-26-381873.md) |
| Gross profit | $m | [153](/filings/0000950170-24-133682.md) | [195 d](/filings/0001193125-26-126210.md) | [139](/filings/0000950170-25-082338.md) | [152](/filings/0000950170-25-113837.md) | [161](/filings/0001193125-25-312757.md) | [201 d](/filings/0001193125-26-126210.md) | [133](/filings/0001193125-26-263736.md) | [143](/filings/0001193125-26-381873.md) | [164](/filings/0001193125-25-312757.md) | [210 d](/filings/0001193125-26-126210.md) | [112](/filings/0001193125-26-263736.md) | [157](/filings/0001193125-26-381873.md) |
| Selling, general and administrative | $m | [135](/filings/0000950170-24-133682.md) | [173 d](/filings/0001193125-26-126210.md) | [127](/filings/0000950170-25-082338.md) | [136](/filings/0000950170-25-113837.md) | [141](/filings/0001193125-25-312757.md) | [158 d](/filings/0001193125-26-126210.md) | [123](/filings/0001193125-26-263736.md) | [129](/filings/0001193125-26-381873.md) | [139](/filings/0001193125-25-312757.md) | [170 d](/filings/0001193125-26-126210.md) | [126](/filings/0001193125-26-263736.md) | [135](/filings/0001193125-26-381873.md) |
| Operating income | $m | [(101)](/filings/0000950170-24-133682.md) | [8.1 d](/filings/0001193125-26-126210.md) | [2.2](/filings/0000950170-25-082338.md) | [2.5](/filings/0000950170-25-113837.md) | [9.3](/filings/0001193125-25-312757.md) | [37.0 d](/filings/0001193125-26-126210.md) | [(2.4)](/filings/0001193125-26-263736.md) | [4.0](/filings/0001193125-26-381873.md) | [16.8](/filings/0001193125-25-312757.md) | [25.9 d](/filings/0001193125-26-126210.md) | [(44.1)](/filings/0001193125-26-263736.md) | [8.2](/filings/0001193125-26-381873.md) |
| Interest expense | $m | [11.7](/filings/0000950170-24-133682.md) | [12.3 d](/filings/0001193125-26-126210.md) | [10.3](/filings/0000950170-25-082338.md) | [10.4](/filings/0000950170-25-113837.md) | [10.3](/filings/0001193125-25-312757.md) | [9.4 d](/filings/0001193125-26-126210.md) | [9.3](/filings/0001193125-26-263736.md) | [9.3](/filings/0001193125-26-381873.md) | [9.4](/filings/0001193125-25-312757.md) | [8.8 d](/filings/0001193125-26-126210.md) | [5.5](/filings/0001193125-26-263736.md) | [1.0](/filings/0001193125-26-381873.md) |
| Income tax | $m | [(0.5)](/filings/0000950170-24-133682.md) | [(2.1) d](/filings/0001193125-26-126210.md) | [(1.6)](/filings/0000950170-25-082338.md) | [(2.6)](/filings/0000950170-25-113837.md) | [(0.7)](/filings/0001193125-25-312757.md) | [9.2 d](/filings/0001193125-26-126210.md) | [(3.4)](/filings/0001193125-26-263736.md) | [(1.6)](/filings/0001193125-26-381873.md) | [2.2](/filings/0001193125-25-312757.md) | [5.0 d](/filings/0001193125-26-126210.md) | [102](/filings/0001193125-26-263736.md) | [4.8](/filings/0001193125-26-381873.md) |
| Net income | $m | [(112)](/filings/0000950170-24-133682.md) | [(8.6) d](/filings/0001193125-26-126210.md) | [(6.4)](/filings/0001193125-25-312757.md) | [(5.3)](/filings/0001193125-25-312757.md) | [(0.6)](/filings/0001193125-25-312757.md) | [18.5 d](/filings/0001193125-26-126210.md) | [(8.3)](/filings/0001193125-26-381873.md) | [(3.7)](/filings/0001193125-26-381873.md) | [5.2](/filings/0001193125-25-312757.md) | [12.3 d](/filings/0001193125-26-126210.md) | [331](/filings/0001193125-26-381873.md) | [3.5](/filings/0001193125-26-381873.md) |
| Diluted EPS | $ per share | [(3.52)](/filings/0000950170-24-133682.md) | not reported | [(0.20)](/filings/0000950170-25-082338.md) | [(0.17)](/filings/0000950170-25-113837.md) | [(0.02)](/filings/0001193125-25-312757.md) | not reported | [(0.27)](/filings/0001193125-26-263736.md) | [(0.12)](/filings/0001193125-26-381873.md) | [0.17](/filings/0001193125-25-312757.md) | not reported | [10.56](/filings/0001193125-26-263736.md) | [0.11](/filings/0001193125-26-381873.md) |
| Basic EPS | $ per share | [(3.52)](/filings/0000950170-24-133682.md) | not reported | [(0.20)](/filings/0000950170-25-082338.md) | [(0.17)](/filings/0000950170-25-113837.md) | [(0.02)](/filings/0001193125-25-312757.md) | not reported | [(0.27)](/filings/0001193125-26-263736.md) | [(0.12)](/filings/0001193125-26-381873.md) | [0.17](/filings/0001193125-25-312757.md) | not reported | [10.74](/filings/0001193125-26-263736.md) | [0.12](/filings/0001193125-26-381873.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-27) | FY2023 (2024-02-02) | Q1 FY2024 (2024-05-03) | Q2 FY2024 (2024-08-02) | Q3 FY2024 (2024-11-01) | FY2024 (2025-01-31) | Q1 FY2025 (2025-05-02) | Q2 FY2025 (2025-08-01) | Q3 FY2025 (2025-10-31) | FY2025 (2026-01-30) | Q1 FY2026 (2026-05-01) | Q2 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [36.8](/filings/0000950170-24-133682.md) | [25.3](/filings/0000950170-25-046044.md) | [27.4](/filings/0000950170-25-082338.md) | [25.6](/filings/0000950170-25-113837.md) | [30.4](/filings/0001193125-25-312757.md) | [16.2](/filings/0001193125-26-126210.md) | [18.1](/filings/0001193125-26-263736.md) | [21.3](/filings/0001193125-26-381873.md) | [36.3](/filings/0001193125-25-312757.md) | [17.7](/filings/0001193125-26-381873.md) | [23.1](/filings/0001193125-26-263736.md) | [16.1](/filings/0001193125-26-381873.md) |
| Current assets | $m | [540](/filings/0000950170-24-133682.md) | [410](/filings/0000950170-25-046044.md) | [405](/filings/0000950170-25-082338.md) | [415](/filings/0000950170-25-113837.md) | [453](/filings/0001193125-25-312757.md) | [370](/filings/0001193125-26-126210.md) | [365](/filings/0001193125-26-263736.md) | [405](/filings/0001193125-26-381873.md) | [461](/filings/0001193125-25-312757.md) | [361](/filings/0001193125-26-381873.md) | [393](/filings/0001193125-26-263736.md) | [428](/filings/0001193125-26-381873.md) |
| Total assets | $m | [948](/filings/0000950170-24-133682.md) | [811](/filings/0000950170-25-046044.md) | [800](/filings/0000950170-25-082338.md) | [803](/filings/0000950170-25-113837.md) | [844](/filings/0001193125-25-312757.md) | [765](/filings/0001193125-26-126210.md) | [760](/filings/0001193125-26-263736.md) | [801](/filings/0001193125-26-381873.md) | [853](/filings/0001193125-25-312757.md) | [751](/filings/0001193125-26-381873.md) | [906](/filings/0001193125-26-263736.md) | [950](/filings/0001193125-26-381873.md) |
| Current liabilities | $m | [291](/filings/0000950170-24-133682.md) | [260](/filings/0000950170-25-046044.md) | [219](/filings/0000950170-25-082338.md) | [253](/filings/0000950170-25-113837.md) | [260](/filings/0001193125-25-312757.md) | [228](/filings/0001193125-26-126210.md) | [197](/filings/0001193125-26-263736.md) | [251](/filings/0001193125-26-381873.md) | [262](/filings/0001193125-25-312757.md) | [224](/filings/0001193125-26-381873.md) | [249](/filings/0001193125-26-263736.md) | [271](/filings/0001193125-26-381873.md) |
| Total liabilities | $m | [697](/filings/0000950170-24-133682.md) | [570](/filings/0000950170-25-046044.md) | [566](/filings/0000950170-25-082338.md) | [576](/filings/0000950170-25-113837.md) | [620](/filings/0001193125-25-312757.md) | [526](/filings/0001193125-26-126210.md) | [530](/filings/0001193125-26-263736.md) | [576](/filings/0001193125-26-381873.md) | [622](/filings/0001193125-25-312757.md) | [507](/filings/0001193125-26-381873.md) | [405](/filings/0001193125-26-263736.md) | [457](/filings/0001193125-26-381873.md) |
| Long-term debt | $m | [215](/filings/0000950170-24-133682.md) | [236](/filings/0000950170-25-046044.md) | [233](/filings/0000950170-25-082338.md) | [230](/filings/0000950170-25-113837.md) | [228](/filings/0001193125-25-312757.md) | [225](/filings/0001193125-26-126210.md) | [222](/filings/0001193125-26-263736.md) | [220](/filings/0001193125-26-381873.md) | [217](/filings/0001193125-25-312757.md) | [214](/filings/0001193125-26-381873.md) | [0.0](/filings/0001193125-26-263736.md) | [0.0](/filings/0001193125-26-381873.md) |
| Current portion of debt | $m | [13.8](/filings/0000950170-24-133682.md) | [13.0](/filings/0000950170-25-046044.md) | [13.0](/filings/0000950170-25-082338.md) | [13.0](/filings/0000950170-25-113837.md) | [13.0](/filings/0001193125-25-312757.md) | [13.0](/filings/0001193125-26-126210.md) | [13.0](/filings/0001193125-26-263736.md) | [13.0](/filings/0001193125-26-381873.md) | [13.0](/filings/0001193125-25-312757.md) | [13.0](/filings/0001193125-26-381873.md) | [0.0](/filings/0001193125-26-263736.md) | [0.0](/filings/0001193125-26-381873.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [251](/filings/0000950170-24-133682.md) | [242](/filings/0001193125-26-126210.md) | [235](/filings/0001193125-25-312757.md) | [227](/filings/0001193125-25-312757.md) | [224](/filings/0001193125-25-312757.md) | [239](/filings/0001193125-26-381873.md) | [230](/filings/0001193125-26-381873.md) | [225](/filings/0001193125-26-381873.md) | [231](/filings/0001193125-25-312757.md) | [244](/filings/0001193125-26-381873.md) | [501](/filings/0001193125-26-381873.md) | [493](/filings/0001193125-26-381873.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-27) | Q4 FY2023 (2024-02-02) | Q1 FY2024 (2024-05-03) | Q2 FY2024 (2024-08-02) | Q3 FY2024 (2024-11-01) | Q4 FY2024 (2025-01-31) | Q1 FY2025 (2025-05-02) | Q2 FY2025 (2025-08-01) | Q3 FY2025 (2025-10-31) | Q4 FY2025 (2026-01-30) | Q1 FY2026 (2026-05-01) | Q2 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(18.2) d](/filings/0000950170-24-133682.md) | [93.9 d](/filings/0001193125-26-126210.md) | [(25.8)](/filings/0000950170-25-082338.md) | [30.7 d](/filings/0000950170-25-113837.md) | [(17.1) d](/filings/0001193125-25-312757.md) | [65.4 d](/filings/0001193125-26-126210.md) | [(22.5)](/filings/0001193125-26-263736.md) | [22.9 d](/filings/0001193125-26-381873.md) | [(15.7) d](/filings/0001193125-25-312757.md) | [64.8 d](/filings/0001193125-26-126210.md) | [(74.2)](/filings/0001193125-26-263736.md) | [(12.3) d](/filings/0001193125-26-381873.md) |
| Capital expenditure | $m | [5.7 d](/filings/0000950170-24-133682.md) | [6.4 d](/filings/0001193125-26-126210.md) | [6.7](/filings/0000950170-25-082338.md) | [4.7 d](/filings/0000950170-25-113837.md) | [10.7 d](/filings/0001193125-25-312757.md) | [15.6 d](/filings/0001193125-26-126210.md) | [8.3](/filings/0001193125-26-263736.md) | [8.9 d](/filings/0001193125-26-381873.md) | [6.8 d](/filings/0001193125-25-312757.md) | [5.3 d](/filings/0001193125-26-126210.md) | [10.2](/filings/0001193125-26-263736.md) | [13.8 d](/filings/0001193125-26-381873.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [3.0 d](/filings/0000950170-23-068256.md) | [2.1 d](/filings/0000950170-24-041066.md) | [1.0](/filings/0000950170-24-069354.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-28) | Q1 FY2023 (2023-04-28) | Q2 FY2023 (2023-07-28) | Q3 FY2023 (2023-10-27) | Q1 FY2024 (2024-05-03) | Q2 FY2024 (2024-08-02) | Q3 FY2024 (2024-11-01) | Q1 FY2025 (2025-05-02) | Q2 FY2025 (2025-08-01) | Q3 FY2025 (2025-10-31) | Q1 FY2026 (2026-05-01) | Q2 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [33.1](/filings/0000950170-23-068256.md) | [32.4](/filings/0000950170-24-069354.md) | [32.1](/filings/0000950170-24-104054.md) | [31.9](/filings/0000950170-24-133682.md) | [31.4](/filings/0000950170-25-082338.md) | [31.4](/filings/0000950170-25-113837.md) | [31.1](/filings/0001193125-25-312757.md) | [30.9](/filings/0001193125-26-263736.md) | [30.7](/filings/0001193125-26-381873.md) | [30.9](/filings/0001193125-25-312757.md) | [31.3](/filings/0001193125-26-263736.md) | [30.1](/filings/0001193125-26-381873.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 29,544,154 at 2026-09-01, from the cover of the [10-Q filed 2026-09-03](/filings/0001193125-26-381873.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.